Aaron T. Gerds, MD, discusses the unmet needs in the treatment of essential thrombocythemia, as well as novel methods for approaching disease treatment.

Ongoing research such as the 'Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)' is studying how clinical and genetic patterns in low-risk myelofibrosis could inform disease ...

Business Wire Positive Late-Breaking Data for Incyte’s First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025 15 Jun 2025 WILMINGTON, Del.

John Mascarenhas, MD, discusses the rationale, mechanism, and design of the phase 1 INCA33989-101 and -102 trials investigating a CAL-R–targeted antibody for patients with essential thrombocythemia.

Among secondary thrombocytosis, surgery including coronary artery by-pass, major abdominal surgery and especially splenectomy [3, 1] are fairly common.

Is thrombocytosis after major joint surgery associated with higher rates of DVT and worse outcomes? This new study investigates.

Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?